Extract

The primary question is what is the optimal treatment for patients with resistant oligoarthritis. The primary outcome is reduction in synovitis seen on US scan at 8 weeks following administration of IA steroid (standard care), IA infliximab or IV infliximab.

Inclusion criteria

• Seronegative oligoarthritis (inflammatory arthritis of 4 active joints or less)

Links

• ictrp
• euctr